Mitesh J Borad1, Gregory J Gores, Lewis R Roberts. 1. aDivision of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona bDepartment of Molecular Medicine cDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
PURPOSE OF REVIEW: This review will cover the role of the fibroblast growth factor pathway in the pathogenesis, targeted therapy potential and prognostic value in patients with cholangiocarcinoma (CCA). RECENT FINDINGS: Recent studies that have identified fibroblast growth factor receptor 2 (FGFR2) fusions, prognostic implications of FGFR2 fusions, treatment strategies that target FGFR2 in CCA and future directions for understanding and targeting the FGFR2 pathway in this disease, will be discussed. SUMMARY: Understanding the role of the FGFR2 pathway as a disease pathogenetic mechanism and the ability to develop targeted therapies and diagnostics surrounding this concept are critical elements toward developing novel targeted approaches in CCA.
PURPOSE OF REVIEW: This review will cover the role of the fibroblast growth factor pathway in the pathogenesis, targeted therapy potential and prognostic value in patients with cholangiocarcinoma (CCA). RECENT FINDINGS: Recent studies that have identified fibroblast growth factor receptor 2 (FGFR2) fusions, prognostic implications of FGFR2 fusions, treatment strategies that target FGFR2 in CCA and future directions for understanding and targeting the FGFR2 pathway in this disease, will be discussed. SUMMARY: Understanding the role of the FGFR2 pathway as a disease pathogenetic mechanism and the ability to develop targeted therapies and diagnostics surrounding this concept are critical elements toward developing novel targeted approaches in CCA.
Authors: Wei-meng Zhao; Lihong Wang; Hangil Park; Sophea Chhim; Melanie Tanphanich; Masakazu Yashiro; K Jin Kim Journal: Clin Cancer Res Date: 2010-07-29 Impact factor: 12.531
Authors: Melanie B Laederich; Catherine R Degnin; Gregory P Lunstrum; Paul Holden; William A Horton Journal: J Biol Chem Date: 2011-04-12 Impact factor: 5.157
Authors: Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater Journal: N Engl J Med Date: 2010-04-08 Impact factor: 91.245
Authors: Jaime Acquaviva; Suqin He; Chaohua Zhang; John-Paul Jimenez; Masazumi Nagai; Jim Sang; Manuel Sequeira; Donald L Smith; Luisa Shin Ogawa; Takayo Inoue; Noriaki Tatsuta; Margaret A Knowles; Richard C Bates; David A Proia Journal: Mol Cancer Res Date: 2014-04-30 Impact factor: 5.852
Authors: Joseph M Gozgit; Rachel M Squillace; Matthew J Wongchenko; David Miller; Scott Wardwell; Qurish Mohemmad; Narayana I Narasimhan; Frank Wang; Tim Clackson; Victor M Rivera Journal: Cancer Chemother Pharmacol Date: 2013-03-07 Impact factor: 3.333
Authors: Choon Kiat Ong; Chutima Subimerb; Chawalit Pairojkul; Sopit Wongkham; Ioana Cutcutache; Willie Yu; John R McPherson; George E Allen; Cedric Chuan Young Ng; Bernice Huimin Wong; Swe Swe Myint; Vikneswari Rajasegaran; Hong Lee Heng; Anna Gan; Zhi Jiang Zang; Yingting Wu; Jeanie Wu; Ming Hui Lee; DaChuan Huang; Pauline Ong; Waraporn Chan-on; Yun Cao; Chao-Nan Qian; Kiat Hon Lim; Aikseng Ooi; Karl Dykema; Kyle Furge; Veerapol Kukongviriyapan; Banchob Sripa; Chaisiri Wongkham; Puangrat Yongvanit; P Andrew Futreal; Vajarabhongsa Bhudhisawasdi; Steve Rozen; Patrick Tan; Bin Tean Teh Journal: Nat Genet Date: 2012-05-06 Impact factor: 38.330
Authors: Rondell P Graham; Emily G Barr Fritcher; Ekaterina Pestova; John Schulz; Leonid A Sitailo; George Vasmatzis; Stephen J Murphy; Robert R McWilliams; Steven N Hart; Kevin C Halling; Lewis R Roberts; Gregory J Gores; Fergus J Couch; Lizhi Zhang; Mitesh J Borad; Benjamin R Kipp Journal: Hum Pathol Date: 2014-04-13 Impact factor: 3.466
Authors: Yi-Mi Wu; Fengyun Su; Shanker Kalyana-Sundaram; Nickolay Khazanov; Bushra Ateeq; Xuhong Cao; Robert J Lonigro; Pankaj Vats; Rui Wang; Su-Fang Lin; Ann-Joy Cheng; Lakshmi P Kunju; Javed Siddiqui; Scott A Tomlins; Peter Wyngaard; Seth Sadis; Sameek Roychowdhury; Maha H Hussain; Felix Y Feng; Mark M Zalupski; Moshe Talpaz; Kenneth J Pienta; Daniel R Rhodes; Dan R Robinson; Arul M Chinnaiyan Journal: Cancer Discov Date: 2013-04-04 Impact factor: 39.397
Authors: Yu Wang; Xiwei Ding; Shaoqing Wang; Catherine D Moser; Hassan M Shaleh; Essa A Mohamed; Roongruedee Chaiteerakij; Loretta K Allotey; Gang Chen; Katsuyuki Miyabe; Melissa S McNulty; Albert Ndzengue; Emily G Barr Fritcher; Ryan A Knudson; Patricia T Greipp; Karl J Clark; Michael S Torbenson; Benjamin R Kipp; Jie Zhou; Michael T Barrett; Michael P Gustafson; Steven R Alberts; Mitesh J Borad; Lewis R Roberts Journal: Cancer Lett Date: 2016-05-20 Impact factor: 8.679
Authors: Shunichi Tsuge; Behnam Saberi; Yulan Cheng; Zhixiong Wang; Amy Kim; Harry Luu; John M Abraham; Maria D Ybanez; James P Hamilton; Florin M Selaru; Carlos Villacorta-Martin; Felix Schlesinger; Benjamin Philosophe; Andrew M Cameron; Qingfeng Zhu; Robert Anders; Ahmet Gurakar; Stephen J Meltzer Journal: Gastrointest Tumors Date: 2019-04-10
Authors: Terence G Hall; Yi Yu; Sudharshan Eathiraj; Yunxia Wang; Ronald E Savage; Jean-Marc Lapierre; Brian Schwartz; Giovanni Abbadessa Journal: PLoS One Date: 2016-09-14 Impact factor: 3.240
Authors: Andreas Reicher; Antoneicka L Harris; Felix Prinz; Tobias Kiesslich; Miaoyan Wei; Rupert Öllinger; Roland Rad; Martin Pichler; Lawrence N Kwong Journal: Int J Mol Sci Date: 2020-04-02 Impact factor: 6.208